Saniona, a biotech company focused on CNS and eating disorders has announced the successful completion of preclinical de...
Navitas Life Sciences, a TAKE Solutions Enterprise has announced that it will be acquiring Life Sciences services player...
Boehringer Ingelheim (Canada) Ltd. and IBM Canada have announced at the Healthcare Information and Management Systems So...
Pfizer Inc. and Astellas Pharma Inc. have announced the results from the Phase 3 ARCHES trial in men with metastatic hor...
The annual J.P. Morgan Healthcare Conference is the premier investor conference focused exclusively on companies definin...
Taiwan Liposome Company, a clinical-stage specialty pharmaceutical company dedicated to the development and commercializ...
Eisai Co., Ltd. and Purdue Pharma L.P. announced a six-month results from SUNRISE 2, a long-term Phase 3 clinical study ...
Spero Therapeutics, a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and ...
Ionis Pharma, Inc. the leader in antisense therapeutics, has announced that its partner Roche has enrolled the firs...
A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at...
Dicerna Pharmaceuticals, a leading developer of RNA interference (RNAi) therapeutics, today announced the dosing of the ...
OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced the nomination of OLX10020 as a clin...
Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transfor...
Clinical stage Biopharmaceutical Company, Gamida Cell Ltd. and Be The Match BioTherapies, a subsidiary of the National M...
UK based Biotechnology Company, Redx has announced that the UK’s Medicines and Healthcare products Regulatory Agen...
Abcam, a global innovator in life science reagents and tools, and the Loulou Foundation, a private UK-based foundation d...
TaiwanJ Pharmaceuticals, a specialty pharmaceutical company dedicated to the development and commercialization of small ...
Eli Lilly and Company has reported that the results of ANNOUNCE, the Phase 3 study of LARTRUVO (olaratumab), in combinat...
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Fo...
United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brai...
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant compan...
Clinical-Stage Biotechnology company, Immunocore has announced David Berman as its new Head of Research and Development....
Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines has ...
A research consortium of NIH recently began enrolling patients in a clinical trial examining whether fecal microbiota tr...
A clinical stage pharma company, UroGen Pharma developing treatments to address unmet needs in the field of urology has ...
